| Ranbaxy has gained 3% (Rs 30) to Rs 1,014. Other pharma pivotals are unchanged with steady gains. |
Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
| Ranbaxy has gained 3% (Rs 30) to Rs 1,014. Other pharma pivotals are unchanged with steady gains. |
First Published: Jan 27 2005 | 2:15 PM IST